Choice Hotels International to Present at Oppenheimer 8th Annual Consumer Growth, Gaming, Lodging and Leisure Conference
Company Added
Company Removed
Apply to Request List

Choice Hotels International to Present at Oppenheimer 8th Annual Consumer Growth, Gaming, Lodging and Leisure Conference

SILVER SPRING, Md., July 7 // PRNewswire-FirstCall // -- Choice Hotels International, Inc. (NYSE: CHH) today announced that the company is scheduled to present at the Oppenheimer 8th Annual Consumer Growth, Gaming, Lodging and Leisure Conference on Thursday, July 10, 2008 at 11:30 a.m. EDT. Stephen P. Joyce, the company's president and chief executive officer, will be addressing investors at the conference, which will take place at the Four Seasons Hotel in Boston.

The presentation will be broadcast live over the Internet at investor.choicehotels.com. The webcast will be archived until July 28, 2008 and can also be accessed at http://www.veracast.com/webcasts/opco/consumer08/49307233.cfm.

About Choice Hotels

Choice Hotels International franchises more than 5,600 hotels, representing more than 455,000 rooms, in the United States and 38 countries and territories. As of March 31, 2008, 986 hotels are under development in the United States, representing 79,276 rooms, and an additional 96 hotels, representing 8,321 rooms, are under development in more than 20 countries and territories. The company's Comfort Inn, Comfort Suites, Quality, Sleep Inn, Clarion, Cambria Suites, MainStay Suites, Suburban Extended Stay Hotel, Econo Lodge and Rodeway Inn brands serve guests worldwide.

Additional corporate information may be found on the Choice Hotels Web site, which may be accessed at http://www.choicehotels.com.

Choice Hotels, Choice Hotels International, Comfort Inn, Comfort Suites, Quality, Sleep Inn, Clarion, Cambria Suites, MainStay Suites, Suburban Extended Stay Hotel, Econo Lodge and Rodeway Inn are proprietary trademarks and service marks of Choice Hotels International.



SOURCE Choice Hotels International, Inc.

###

Comments:

comments powered by Disqus
Share This Page

Subscribe to our Newsletters